UConn appoints BI Pharmaceuticals chair
The UConn Board of Trustees has approved the appointment of José Manautou, Department Head of Pharmaceutical Sciences and Professor of Pharmacology & Toxicology, as the School of...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The UConn Board of Trustees has approved the appointment of José Manautou, Department Head of Pharmaceutical Sciences and Professor of Pharmacology & Toxicology, as the School of...
After having won FDA approval for the psychiatric drug Igalmi, BioXcel is making a major new move: pivoting its focus to commercialization and spinning out much of...
View this email in your browser Career News – April 26, 2022 Golden Ticket...
LambdaVision’s signature product — an artificial retina that could change the lives of thousands with degenerative eye diseases — is under development aboard the International...
New data show that migraine patients treated with Biohaven’s Nurtec ODT decreased their use of opioids. “Results demonstrate a clinically meaningful reduction in opioid use in...
Yale has announced an ambitious new initiative to support and expand innovation and entrepreneurship across the university and throughout the greater New Haven region. Yale Ventures will...
Bioasis has entered into a research collaboration with Janssen Biotech, one of the pharmaceutical companies of Johnson & Johnson. Under the terms of the agreement, Janssen...
As a high-tech enterprise, Sino Biological specializes in the research, development, production and sales of biological reagents such as recombinant proteins, antibodies, genes and culture media. The...
Stamford-based Sema4, working in partnership with researchers from the Icahn School of Medicine at Mount Sinai in New York City, have published a study in Nature...